Cargando…
Tenofovir alafenamide fumarate therapy in subjects with positive HBV-DNA and normal levels of alanine transaminase: a study protocol for a randomised controlled trial
INTRODUCTION: The current clinical guidelines do not recommend antiviral therapy for subjects with positive hepatitis B virus (HBV)-DNA and normal alanine transaminase (ALT). In this study, we will assess the safety and efficacy of tenofovir alafenamide fumarate (TAF) in the treatment of adults with...
Autores principales: | Wang, Lu, Wu, Lina, Li, Xuejun, Zhang, Ying, Lai, Jing, Zhu, Xiang, Xie, Chan, Peng, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375735/ https://www.ncbi.nlm.nih.gov/pubmed/34408049 http://dx.doi.org/10.1136/bmjopen-2020-048410 |
Ejemplares similares
-
Clinical Characteristics of Hepatitis B Virus Patients After Switching to Tenofovir Alafenamide Fumarate: A Retrospective Observational Study
por: Alghamdi, Abdullah S, et al.
Publicado: (2020) -
3-year Treatment of Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate for Chronic HBV Infection in China
por: Hou, Jinlin, et al.
Publicado: (2021) -
Gender differences in demographic and clinical characteristics in patients with HBV-related liver diseases in China
por: Liu, Mei, et al.
Publicado: (2022) -
Prevalence and clinical correlates of insomnia symptoms and their association with quality of life in Chinese patients with HBV-related liver disease
por: Zhao, Jing, et al.
Publicado: (2021) -
Antiviral kinetics of tenofovir alafenamide and tenofovir disoproxil fumarate over 24 weeks in women of childbearing potential with chronic HBV
por: Pan, Calvin Q., et al.
Publicado: (2021)